Total Lymphoid Irradiation in the Treatment of Heart Transplant Rejection: Single Institution Long-Term Results
International journal of radiation oncology, biology, physics(2023)
摘要
TLI is a safe and effective treatment for control of intractable cardiac rejection. The episodes of acute rejection and immunosuppressant requirements are decreased, but with long-term follow up, these patients continue to experience rejection. However, TLI lowers the frequency of ISHLT moderate to severe rejection episodes for up to 6.4 years. There was no increased risk of severe infections and there were only minimal short- and long-term grade 2 or higher radiation toxicities.
更多查看译文
关键词
total lymphoid irradiation,heart transplant rejection,heart transplant,long-term
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要